In summary, our results have confirmed that inhibiting mTORC1 in the brain microvascular endothelium ameliorates diabetic Aβ brain deposition and cognitive impairment via the SREBP1/LRP1 signaling pathway. This evidence concerns the gene SREBF1 and Cognitive impairment.